Keratoconjunctivitis Sicca
3 competing products in clinical development for Keratoconjunctivitis Sicca.
Pipeline by Phase
Phase 2/31
Phase 32
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| OTX-101 0.09% | Sun Pharmaceutical | Phase 3 | Completed | 40 |
| cyclosporine + vehicle of OTX-101 | Sun Pharmaceutical | Phase 3 | Completed | 40 |
| OTX-101 0.05% + OTX-101 0.09% + Vehicle | Sun Pharmaceutical | Phase 2/3 | Completed | 38 |